Publication
Efficacy and safety of dolutegravir plus emtricitabine versus standard ART for the maintenance of HIV-1 suppression: 48-week results of the factorial, randomized, non-inferiority SIMPL'HIV trial
Journal Paper/Review - Nov 10, 2020
Sculier Delphine, Calmy Alexandra, Egger Matthias, Limacher Andreas, Schmid Patrick, Günthard Huldrych F, Decosterd Laurent A, Metzner Karin J, Buzzi Marta, Cavassini Matthias, Veraguth Katja, Braun Dominique L, Bernasconi Enos, Stoeckle Marcel, Marinosci Annalisa, Yerly Sabine, Wandeler Gilles, and the Swiss HIV Cohort Study (SHCS)
Sculier, Delphine
3
0
Wandeler, Gilles
29
0
Yerly, Sabine
69
0
Marinosci, Annalisa
2
0
Stoeckle, Marcel
24
0
Bernasconi, Enos
220
0
Braun, Dominique L
25
0
Veraguth, Katja
2
1
Cavassini, Matthias
171
0
Buzzi, Marta
1
0
Metzner, Karin J
12
0
Decosterd, Laurent A
6
0
Günthard, Huldrych F
123
0
Schmid, Patrick
Division of Infectious Diseases, Infection Prevention and Travel Medicine · Dept. I
124
7
Limacher, Andreas
11
0
Egger, Matthias
20
0
Calmy, Alexandra
102
0
and the Swiss HIV Cohort Study (SHCS),
2
0